首页> 外国专利> Cephalosporin derivatives, process for their preparation and their antibiotic application.

Cephalosporin derivatives, process for their preparation and their antibiotic application.

机译:头孢菌素衍生物,其制备方法和抗生素应用。

摘要

For the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE 1. Cephalosporin derivatives of general formula : see diagramm : EP0178980,P46,F1 in which : - X is an oxygen atom or a sulfur atom - n is zero, 1 or 2, - R1 , R2 and R3 each designate, a hydrogen atom or else - R1 and R2 designate a hydrogen atom or a methyl group, and R3 designates a carboxyl or cyclopropyl group or else - R1 and R2 taken together with the carbon atom to which they are linked form a cyclobutyl or cyclopentyl group and R3 is a carboxyl group, - B is the residue of a primary or secondary amine selected from the following groups : - Z-NH2 where Z is an alkylene group with a straight or branched chain having from 2 to 7 carbon atoms, possibly interrupted by a sulfur atom, or else Z is a 1,3-cyclohexylene or 1,4-cyclohexylene group, - Z'-Alk-NH-R where Z' is a 1,2-phenylene or 1,3-phenylene or 1,4-phenylene group possibly substituted by 1, 2 or 3 methyl groups or else Z' is 1,2-cyclohexylene, 1,3-cyclohexylene or 1,4-cyclohexylene group. Alk is a straight or branched alkylene group having from 1 to 3 carbon atoms, possibly interrupted by a sulfur atom, R is a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms, see diagramm : EP0178980,P46,F2 where Z'' is a 1,3-phenylene or 1,4-phenylene group, Y is an alkylene group (CH2 )m in which m = 1, 2 or 3, R' is hydrogen or methyl and R is as defined above, - Z''-CO-NH-Y-NH2 where Z'' and Y are as defined above, - Z''-Y'-NH-CO-Y-NH2 where Z'' and Y are as defined above and Y' is a straight or branched alkylene group with 1 or 2 carbon atoms, see diagramm : EP0178980,P47,F3 where n = 0 or 1 and Y is as defined above, - a 2-piperidyl, 3-piperidyl or 4-piperidyl group possibly substituted on the nitrogen atom by a -CO-Y-NH2 group where Y is as defined above, - a group see diagramm : EP0178980,P47,F4 - the bicyclic group see diagramm : EP0178980,P47,F5 as well as the pharmaceutically acceptable salts and esters thereof. For the Contracting State : AT 1. Process for the preparation of the cephalosporin derivatives of general formula : see diagramm : EP0178980,P49,F1 in which : - X is an oxygen atom or a sulfur atom - n is zero, 1 or 2 - R1 , R2 and R3 each designate, a hydrogen atom or else - R1 and R2 designate a hydrogen atom or a methyl group, and R3 designates a carboxyl or cyclopropyl group or else - R1 and R2 taken together with the carbon atom to which they are linked from a cyclobutyl or cyclopentyl group and R3 is a carboxyl group, - B is the residue of a primary or secondary amine selected by the following groups : - Z-NH2 where Z is an alkylene group with a straight or branched chain having from 2 to 7 carbon atoms, possibly interrupted by a sulfur atom, or else Z is a 1,3-cyclohexylene or 1,4-cyclohexylene group, - Z'-Alk-NH-R where Z' is a 1,2-phenylene or 1,3-phenylene or 1,4-phenylene group possibly substituted by 1, 2 or 3 methyl groups or else Z' is 1,2-cyclohexylene, 1,3-cyclohexylene or 1,4-cyclohexylene group. Alk is a straight or branched alkylene group having from 1 to 3 carbon atoms, possibly interrupted by a sulfur atom, R is a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms, see diagramm : EP0178980,P49,F2 where Z'' is a 1,3-phenylene or 1,4-phenylene group, Y is an alkylene group (CH2 )m in which m = 1, 2 or 3, R' is hydrogen or methyl and R is as defined above, - Z''-CO-NH-Y-NH2 where Z'' and Y are as defined above, - Z''-Y'-NH-CO-Y-NH2 where Z'' and Y are as defined above and Y' is a straight or branched alkylene group with 1 or 2 carbon atoms, see diagramm : EP0178980,P49,F3 where n = 0 or 1 and Y is as defined above, - a 2-piperidyl, 3-piperidyl or 4-piperidyl group possibly substituted on the nitrogen atom by a -CO-Y-NH2 group where Y is as defined above, - a group see diagramm : EP0178980,P49,F4 - the bicyclic group see diagramm : EP0178980,P49,F5 as well as the pharmaceutically acceptable salts and esters thereof, characterized in that said process consists : 1) in reacting on the compound of formula : see diagramm : EP0178980,P50,F6 in which R1 and R2 are as defined above, R'3 is hydrogen, a cyclopropyl group or a readily labile ester group, of which the amine function has been protected beforehand, the acid or thioacid of formula B'-(CH2 )n -COXH, in which X and n are as defined above, B' is the B group such as defined above, in which the amine function is protected, 2) in subjecting the resulting compound to the action of phosphorous tribromide at low temperature and within a solvent, in order to eliminate the S-oxide function, 3) in eliminating the protecting groups present on the amine and carboxylic functions, by hydrolysis in acid medium, 4) in isolating the resulting compound of formula (I) in the form of a salt of amine group B, 5) in optionally converting said salt into another salt of amine group B, 6) in optionally isolating the expected compound of formula 1, from a salt of amine group B, by the action of a base, and in optionally converting said compound, by known methods, into a salt or an ester deriving from one or two carboxylic groups present in the molecule.
机译:对于缔约国:BE,CH,DE,FR,GB,IT,LI,LU,NL,SE 1.通式的头孢菌素衍生物:参见示意图:EP0178980,P46,F1其中:-X是氧原子或硫原子-n为零,1或2,-R1,R2和R3各自代表氢原子或其他原子-R1和R2代表氢原子或甲基,而R3代表羧基或环丙基;或- R 1和R 2与它们所连接的碳原子一起形成环丁基或环戊基,R 3是羧基,-B是选自以下组的伯胺或仲胺的残基:-Z-NH2是具有直链或支链的碳原子数为2至7的亚烷基,可能被硫原子中断,或者Z为1,3-亚环己基或1,4-亚环己基,-Z'-Alk-NH -R其中Z′为可能被1、2或3个甲基取代的1,2-亚苯基或1,3-亚苯基或1,4-亚苯基,否则Z'为1,2-亚环己基,1,3-六面体亚乙烯基或1,4-亚环己基。 Alk是具有1至3个碳原子的直链或支链亚烷基,可能被硫原子中断,R是氢原子或具有1至3个碳原子的烷基,参见图:EP0178980,P46,F2,其中Z ''为1,3-亚苯基或1,4-亚苯基,Y为亚烷基(CH2)m,其中m = 1,2或3,R'为氢或甲基,R如上定义,- Z''-CO-NH-Y-NH2其中Z''和Y如上定义;-Z''-Y'-NH-CO-Y-NH2其中Z''和Y如上定义; Y'是具有1个或2个碳原子的直链或支链亚烷基,请参见示意图:EP0178980,P47,F3,其中n = 0或1,Y的定义如上,-2-哌啶基,3-哌啶基或4-哌啶基在氮原子上被-CO-Y-NH2基团取代,其中Y如上定义,-基团见图:EP0178980,P47,F4-双环基团见图:EP0178980,P47,F5,以及药学上可接受的盐和酯。对于缔约国:AT 1.通式为头孢菌素衍生物的制备方法:参见示意图:EP0178980,P49,F1其中:-X为氧原子或硫原子-n为零,1或2- R 1,R 2和R 3各自表示氢原子,或者-R 1和R 2表示氢原子或甲基,并且R 3表示羧基或环丙基,或者-R 1和R 2与它们所涉及的碳原子一起由环丁基或环戊基连接,且R3为羧基,-B为选自以下基团的伯胺或仲胺的残基:-Z-NH2,其中Z为直链或支链的亚烷基,具有2碳原子数为7的碳原子,可能被硫原子打断,或者Z为1,3-亚环己基或1,4-亚环己基,-Z'-Alk-NH-R,其中Z'为1,2-亚苯基或可能被1、2或3个甲基取代的1,3-亚苯基或1,4-亚苯基,否则Z'为1,2-亚环己基,1,3-亚环己基或1,4-亚环己基。 Alk是具有1至3个碳原子的直链或支链亚烷基,可能被硫原子中断,R是氢原子或具有1至3个碳原子的烷基,参见图:EP0178980,P49,F2,其中Z ''为1,3-亚苯基或1,4-亚苯基,Y为亚烷基(CH2)m,其中m = 1,2或3,R'为氢或甲基,R如上定义,- Z''-CO-NH-Y-NH2其中Z''和Y如上定义;-Z''-Y'-NH-CO-Y-NH2其中Z''和Y如上定义; Y'是具有1个或2个碳原子的直链或支链亚烷基,请参见示意图:EP0178980,P49,F3,其中n = 0或1,Y的定义如上,-2-哌啶基,3-哌啶基或4-哌啶基在氮原子上被-CO-Y-NH2基团取代,其中Y如上定义,-基团参见图:EP0178980,P49,F4-双环基团参见图:EP0178980,P49,F5,以及药学上可接受的其盐和酯,其特征在于所述方法包括:1)与下式的化合物反应时:参见示意图:EP0178980,P50,F6其中R1和R2如上定义,R'3为氢,环丙基或易不稳定的酯基,其胺官能团已被保护事先,式B′-(CH 2)n -COXH的酸或硫代酸,其中X和n如上所定义,B′是如上所定义的B基团,其中胺官能团被保护,2)在为了在低温下和在溶剂中对三溴化磷进行处理,以消除S-氧化物的功能,3)通过在酸性介质中水解4来消除胺和羧基上存在的保护基,4 )在以胺基团B,5的盐的形式分离所得的式(I)化合物中)在任选地将所需的式1化合物从碱作用下胺基B的盐以及通过已知方法任选地将所述化合物转化为源自分子中存在的一个或两个羧基的盐或酯。

著录项

  • 公开/公告号ES8609342A1

    专利类型

  • 公开/公告日1986-09-01

    原文格式PDF

  • 申请/专利权人 SOCIEDAD ANONIMA FRANCESA SANOFI;

    申请/专利号ES19850547955

  • 发明设计人

    申请日1985-09-26

  • 分类号C07D501/34;A61K31/545;

  • 国家 ES

  • 入库时间 2022-08-22 07:37:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号